Stock Track | Viatris Plunges Over 20% on Disappointing Q4 Results and Weak 2025 Guidance

Stock Track

Feb 27, 2025

Shares of Viatris Inc. (VTRS) plummeted over 20% in pre-market trading on Thursday, following the company's release of disappointing fourth-quarter 2024 financial results and weaker-than-expected guidance for 2025.

The pharmaceutical giant reported adjusted earnings per share of $0.54 for Q4 2024, missing analysts' consensus estimate of $0.57 by 5.26%. Additionally, Viatris' quarterly revenue of $3.52 billion fell short of the expected $3.61 billion, marking a year-over-year decline of 8.13%.

The company's 2025 outlook also fell short of market expectations. Viatris forecast 2025 revenue between $13.5 billion and $14 billion, below analysts' estimates of $14.27 billion. Furthermore, the company expects 2025 adjusted earnings per share between $2.12 and $2.26, compared with estimates of $2.59.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1198786364"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1198786364\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1198786364?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-27 22:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1198786364","market":"us","top_or_hot":-1,"title":"Stock Track | Viatris Plunges Over 20% on Disappointing Q4 Results and Weak 2025 Guidance","media":"Stock Track","content":"<p>Shares of Viatris Inc. (VTRS) plummeted over 20% in pre-market trading on Thursday, following the company's release of disappointing fourth-quarter 2024 financial results and weaker-than-expected guidance for 2025.</p>\n\n<p>The pharmaceutical giant reported adjusted earnings per share of $0.54 for Q4 2024, missing analysts' consensus estimate of $0.57 by 5.26%. Additionally, Viatris' quarterly revenue of $3.52 billion fell short of the expected $3.61 billion, marking a year-over-year decline of 8.13%.</p>\n\n<p>The company's 2025 outlook also fell short of market expectations. Viatris forecast 2025 revenue between $13.5 billion and $14 billion, below analysts' estimates of $14.27 billion. Furthermore, the company expects 2025 adjusted earnings per share between $2.12 and $2.26, compared with estimates of $2.59.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Viatris Plunges Over 20% on Disappointing Q4 Results and Weak 2025 Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Viatris Plunges Over 20% on Disappointing Q4 Results and Weak 2025 Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-27 22:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Viatris Inc. (VTRS) plummeted over 20% in pre-market trading on Thursday, following the company's release of disappointing fourth-quarter 2024 financial results and weaker-than-expected guidance for 2025.</p>\n\n<p>The pharmaceutical giant reported adjusted earnings per share of $0.54 for Q4 2024, missing analysts' consensus estimate of $0.57 by 5.26%. Additionally, Viatris' quarterly revenue of $3.52 billion fell short of the expected $3.61 billion, marking a year-over-year decline of 8.13%.</p>\n\n<p>The company's 2025 outlook also fell short of market expectations. Viatris forecast 2025 revenue between $13.5 billion and $14 billion, below analysts' estimates of $14.27 billion. Furthermore, the company expects 2025 adjusted earnings per share between $2.12 and $2.26, compared with estimates of $2.59.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VTRS","symbol_name":"Viatris Inc.","start_time":0,"source_url":"","article_id":"1198786364","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1198786364","pubTimestamp":1740667812,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Viatris Inc.  plummeted over 20% in pre-market trading on Thursday, following the company's release of disappointing fourth-quarter 2024 financial results and weaker-than-expected guidance for 2025.The pharmaceutical giant reported adjusted earnings per share of $0.54 for Q4 2024, missing analysts' consensus estimate of $0.57 by 5.26%. Additionally, Viatris' quarterly revenue of $3.52 billion fell short of the expected $3.61 billion, marking a year-over-year decline of 8.13%.The compan","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"VTRS":"Viatris Inc."},"translate_title":"股票赛道Viatris因第四季度业绩令人失望和2025年指引疲弱而暴跌超过20%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VTRS":1},"content_text":"Shares of Viatris Inc. (VTRS) plummeted over 20% in pre-market trading on Thursday, following the company's release of disappointing fourth-quarter 2024 financial results and weaker-than-expected guidance for 2025.\nThe pharmaceutical giant reported adjusted earnings per share of $0.54 for Q4 2024, missing analysts' consensus estimate of $0.57 by 5.26%. Additionally, Viatris' quarterly revenue of $3.52 billion fell short of the expected $3.61 billion, marking a year-over-year decline of 8.13%.\nThe company's 2025 outlook also fell short of market expectations. Viatris forecast 2025 revenue between $13.5 billion and $14 billion, below analysts' estimates of $14.27 billion. Furthermore, the company expects 2025 adjusted earnings per share between $2.12 and $2.26, compared with estimates of $2.59.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}